Three Way Takeover Battle – The End: Teva losing $300 million on Mylan stake

Teva bought its 4.6% stake in Mylan at prices of $69-74 per share. the share price is down sharply in premarket trading.

TEVA ,   EREZ VIGODMAN Robert-J-Coury-1 Mylan 320X=p


Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has officially announced that it is withdrawing its bid to buy generic pharmaceuticals rival Mylan N.V. after agreeing to buy Allergan Generics for $40.5 billion. This leaves Teva with a 4.6% stake in Mylan, which it bought for about $1.6 billion, as part of its hostile takeover bid…

For the full story, click here

Published by Globes [online], Israel business news –


Read more about: , , , , , , , , , , , , ,

Wordpress site Developed by Fixing WordPress Problems